Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.66
-0.01 (-0.10%)
Jul 10, 2026, 1:58 PM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $283.83 million as of July 10, 2026. Its market cap has increased by 1.63% in one year.
Market Cap
283.83M
Enterprise Value
177.33M
1-Year Change
1.63%
Ranking
Category
Stock Price
$9.66
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $283.83M, an increase of 70.91%. That is a compound annual growth rate of 22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 283.83M | 51.38% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 317.57M |
| InflaRx | 312.26M |
| Bicycle Therapeutics | 305.77M |
| Eledon Pharmaceuticals | 303.80M |
| Galectin Therapeutics | 303.60M |
| Indaptus Therapeutics | 302.36M |
| MacroGenics | 301.92M |
| SAB Biotherapeutics | 298.21M |